ArticleMDM policy & practice

Measuring Meaningful Benefit-Risk Tradeoffs to Promote Patient-Focused Drug Development in Prader-Willi Syndrome: A Discrete-Choice Experiment.

Jui-Hua Tsai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.